Monday, December 23, 2024
HomeTagsJournal of Medicine

Journal of Medicine

Ionis Announces Publication of Positive Phase 2 Data for Donidalorsen in New England Journal of Medicine

Ionis Pharmaceuticals, Inc., the leader in RNA-targeted therapies, announced the publication of positive Phase 2 data for donidalorsen (formerly IONIS-PKK-LRx) in the New England...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics